Genetic data related to sodium-regulating hormone may help explain hypertension risk in populations of African ancestry

These news tips provide information reported from research presented at the American Heart Association’s High Blood Pressure research 2010 Scientific Sessions.

Abstract P298

New research points to the existence of a gene on chromosome 5 that influences how much aldosterone is produced — which may be excessive in African-descended populations.

“Aldosterone was very important to their early ancestors living in the arid climate of Africa,” said J. Howard Pratt, study co-author. “Dietary intake of sodium in today’s world is much higher, and there may not be the need for the amount of aldosterone produced, leading to a level of sodium balance that places individuals at risk for hypertension.”

aldosterone

Among people of African descent, plasma concentrations of the sodium-regulating hormone, aldosterone, are under genetic influences and are associated with higher diastolic blood pressure readings, new research shows. Aldosterone is produced by the adrenal gland. It regulates a region in the kidney called the distal nephron, which is critically important for controlling sodium balance and blood pressure.

The study examined genetic data from families on the Caribbean island of Tobago. Researchers determined that the population has about 94 percent African ancestry.

After adjusting for the effects of age, gender and body mass index on plasma aldosterone concentration and blood pressure, genes account for 34 percent of the variation in aldosterone concentration among individuals, and about 25 percent of the variation in systolic and diastolic blood pressure, according to Candace M. Kammerer, study co-author.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.